MK-5348-016, NCT00684203: Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; ) |
|
|
| Completed | 2 | 120 | Japan | Vorapaxar, Placebo, Aspirin, ASA, acetylsalicylic acid, Clopidogrel | Merck Sharp & Dohme LLC | Atherosclerosis, Myocardial Ischemia, Myocardial Infarction | 10/07 | 10/07 | | |
NCT00684515: Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017) |
|
|
| Completed | 2 | 90 | NA | Vorapaxar 2.5 mg, Vorapaxar 1 mg, Placebo, Aspirin 75-150 mg | Merck Sharp & Dohme LLC | Cerebral Infarction | 11/07 | 11/07 | | |
